Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lane

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|January 21, 2014
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptorAlaa Abdul-Ridha, Laura López, Peter Keov, et al.
Journal of Medicinal Chemistry|April 24, 2018
A Thieno[2,3- d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D<sub>2</sub> ReceptorTim J Fyfe, Barbara Zarzycka, Herman D Lim, et al.
Journal of Medicinal Chemistry|July 19, 2023
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D<sub>3</sub> (D<sub>3</sub>R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer AnalgesicsAlessandro Bonifazi, Elizabeth Saab, Julie Sanchez, et al.
British Journal of Pharmacology|July 25, 2023
Assessment of the potential of novel and classical opioids to induce respiratory depression in miceRob Hill, Julie Sanchez, Laura Lemel, et al.
Science (New York, N.Y.)|October 4, 2008
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonistVeli-Pekka Jaakola, Mark T Griffith, Michael A Hanson, et al.
Drug and Alcohol Dependence|October 17, 2025
Implementation opportunities for optimizing retention on buprenorphine treatment for people with opioid use disorder in West VirginiaRoman Ivasiy, Lynn M Madden, Judith Feinberg, et al.
Biotechnology Advances|November 19, 2003
Using ecotechnology to address water quality and wetland habitat loss problems in the Mississippi basin: a hierarchical approachJohn W Day, Alejandro Yañéz Arancibia, William J Mitsch, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
Journal of Psychiatric Research|March 1, 2022
Characteristics of suicide attempts associated with lethality and method: A latent class analysis of the Military Suicide Research ConsortiumMolly Gromatsky, Emily R Edwards, Sarah R Sullivan, et al.
ACS Chemical Neuroscience|September 24, 2020
Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D<sub>3</sub> Dopamine ReceptorAmy E Moritz, Alessandro Bonifazi, Adrian M Guerrero, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|January 21, 2014
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptorAlaa Abdul-Ridha, Laura López, Peter Keov, et al.
Journal of Medicinal Chemistry|April 24, 2018
A Thieno[2,3- d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D<sub>2</sub> ReceptorTim J Fyfe, Barbara Zarzycka, Herman D Lim, et al.
Journal of Medicinal Chemistry|July 19, 2023
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D<sub>3</sub> (D<sub>3</sub>R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer AnalgesicsAlessandro Bonifazi, Elizabeth Saab, Julie Sanchez, et al.
British Journal of Pharmacology|July 25, 2023
Assessment of the potential of novel and classical opioids to induce respiratory depression in miceRob Hill, Julie Sanchez, Laura Lemel, et al.
Science (New York, N.Y.)|October 4, 2008
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonistVeli-Pekka Jaakola, Mark T Griffith, Michael A Hanson, et al.
Drug and Alcohol Dependence|October 17, 2025
Implementation opportunities for optimizing retention on buprenorphine treatment for people with opioid use disorder in West VirginiaRoman Ivasiy, Lynn M Madden, Judith Feinberg, et al.
Biotechnology Advances|November 19, 2003
Using ecotechnology to address water quality and wetland habitat loss problems in the Mississippi basin: a hierarchical approachJohn W Day, Alejandro Yañéz Arancibia, William J Mitsch, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
Journal of Psychiatric Research|March 1, 2022
Characteristics of suicide attempts associated with lethality and method: A latent class analysis of the Military Suicide Research ConsortiumMolly Gromatsky, Emily R Edwards, Sarah R Sullivan, et al.
ACS Chemical Neuroscience|September 24, 2020
Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D<sub>3</sub> Dopamine ReceptorAmy E Moritz, Alessandro Bonifazi, Adrian M Guerrero, et al.
Pageof 15